NEUP — Neuphoria Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Neuphoria Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	R2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	10-K	10-K	10-K
Standards:	IFRS	IFRS	USG	USG	USG
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.7	23.2	12.1	12.6	14.2
Net Total Accounts Receivable
Net Total Receivables	0.848	4.68	0.426	0.127	0.012
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23.2	28.9	13.3	13.2	15
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.653	0.465	0.333	0.219	0.105
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	40.7	45.1	28.6	27.6	28.6
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.77	2.32	2.74	3.83	4.22
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5	5.79	6.55	10.2	9.59
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	35.7	39.3	22	17.5	19
Total Liabilities & Shareholders' Equity	40.7	45.1	28.6	27.6	28.6
Total Common Shares Outstanding